Apoptosis of Cardiomyocytes in Explanted and Transplanted Hearts: Comparison of Results from In Situ TUNEL, ISEL, and ISOL Reactions

American Journal of Clinical Pathology

Volumn 121, Issue 1, 2004, Pages 108-116

  Lesauskaite, Vaiva ^a   Epistolato, Maria Carmela ^c   Ivanoviene, Laima ^b   Tanganelli, Piero ^c  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^b KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

Apoptosis; DNA laddering; Heart transplant; In situ end labeling; In situ oligoligation; ISEL; ISOL; Terminal deoxynucleotidyl transferase mediated dUTP nick end labeling; TUNEL

Indexed keywords

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; EXPLANT; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; NICK END LABELING; PRIORITY JOURNAL;

EID: 0345869686     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/7MNN4E8TFAKH3XC9     Document Type: Article

References (32)

1. Davies MJ. Apoptosis in cardiovascular disease. Heart. 1997;77:498-501.
2. Kockx MM. Apoptosis in the atherosclerotic plaque: quantitative and qualitative aspects. Arterioscler Thromb Vasc Biol. 1998;18:1519-1522.
3. Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 1996;335:1182-1189.
4. Saraste A, Voipio-Pulkki LM, Heikkila P, et al. Soluble tumor necrosis factor receptor levels identify a subgroup of heart failure patients with increased cardiomyocyte apoptosis. Clin Chim Acta. 2002;320:65-67.
5. Tamura T, Said S, Lu W, et al. Is apoptosis present in progression to chronic hypertensive heart failure? J Card Fail. 2000;6:37-42.
6. Jollow KC, Sundstrom JB, Gravanis MB, et al. Apoptosis of mononuclear cell infiltrates in cardiac allograft biopsy specimens questions studies of biopsy-cultured cells. Transplantation. 1997;63:1482-1489.
7. Puig M, Ballester M, Matias-Guiu X, et al. Burden of myocardial damage in cardiac allograft rejection: scintigraphic evidence of myocardial injury and histologic evidence of myocyte necrosis and apoptosis. J Nucl Cardiol. 2000;7:132-139.
8. McAllister HA. Histologic grading of cardiac allograft rejection: a quantitative approach. J Heart Transplant. 1990;9:277-282.
9. Alter P, Jobmann M, Meyer E, et al. Apoptosis in myocarditis and dilated cardiomyopathy: does enterovirus genome persistence protect from apoptosis? an endomyocardial biopsy study. Cardiovasc Pathol. 2001;10:229-234.
10. Labat-Moleur F, Guillermet C, Lorimier P, et al. TUNEL apoptotic cell detection in tissue sections: critical evaluation and improvement. J Histochem Cytochem. 1998;46:327-334.
11. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493-501.
12. Wijsman JH, Jonker RR, Keijzer R, et al. A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem. 1993;41:7-12.
13. Nelson DL, Cox MM. DNA metabolism. In: Ryan M, Strange L, Neal V, eds. Lehninger Principles of Biochemistry. 3rd ed. New York, NY: Worth Publishers; 2000:931-978.
14. Kornberg A, Baker TA. Ligases and polynucleotide kinases. In: Kornberg A, Baker TA. DNA Replication. 2nd ed. New York, NY: WH Freeman; 1992:314-315.
15. Didenko VV, Hornsby PJ. Presence of double-strand breaks with single-base 3′ overhangs in cells undergoing apoptosis but not necrosis. J Cell Biol. 1996;135:1369-1376.
16. Kockx MM, Muhring J, Knaapen MW, et al. RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis. Am J Pathol. 1998;152:885-888.
17. Grasl-Kraupp B, Ruttkay-Nadecky B, Koudelka H, et al. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: cautionary note. Hepatology. 1995;21:1465-1468.
18. Panizo-Santos A, Lozano MD, Distefano S, et al. Clinico-pathologic, immunohistochemical, and TUNEL study in early cardiac allograft failure. Cardiovasc Pathol. 2000;9:153-159.
19. Schallock K, Schulz-Schaeffer WJ, Giese A, et al. Postmortem delay and temperature conditions affect the in situ end-labeling (ISEL) assay in brain tissue of mice. Clin Neuropathol. 1997;16:133-136.
20. Petito CK, Roberts B. Effect of postmortem interval on in situ end-labeling of DNA oligonucleosomes. J Neuropathol Exp Neurol. 1995;54:761-765.
21. Tateyama H, Tada T, Hattori H, et al. Effects of prefixation and fixation times on apoptosis detection by in situ end-labeling of fragmented DNA. Arch Pathol Lab Med. 1998;122:252-255.
22. Tamura T, Said S, Lu W, et al. Specificity of TUNEL method depends on duration of fixation. Biotech Histochem. 2000;75:197-200.
23. Vulapalli SR, Chen Z, Chua BH, et al. Cardioselective overexpression of HO-1 prevents I/R-induced cardiac dysfunction and apoptosis. Am J Physiol Heart Circ Physiol. 2002;283:H688-H694.
24. Chen Z, Chua CC, Ho YS, et al. Overexpression of bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. Am J Physiol Heart Circ Physiol. 2001;280:H2313-H2320.
25. Sloop GD, Roa JC, Delgado AG, et al. Histologic sectioning produces TUNEL reactivity: a potential cause of false-positive staining. Arch Pathol Lab Med. 1999;123:529-532.
26. Jerome KR, Vallan C, Jaggi R. The TUNEL assay in the diagnosis of graft-versus-host disease: caveats for interpretation. Pathology. 2000;32:186-190.
27. Saraste A. Morphologic criteria and detection of apoptosis. Herz. 1999;24:189-195.
28. Davison FD, Groves M, Scaravilli F. The effects of formalin fixation on the detection of apoptosis in human brain by in situ end-labeling of DNA. Histochem J. 1995;27:983-988.
29. Stahelin BJ, Marti U, Solioz M, et al. False positive staining in the TUNEL assay to detect apoptosis in liver and intestine is caused by endogenous nucleases and inhibited by diethyl pyrocarbonate. Mol Pathol. 1998;51:204-208.
30. de Boer RA, van Veldhuisen DJ, van der Wijk J, et al. Additional use of immunostaining for active caspase 3 and cleaved actin and PARP fragments to detect apoptosis in patients with chronic heart failure. J Card Fail. 2000;6:330-337.
31. Kanoh M, Takemura G, Misao J, et al. Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair. Circulation. 1999;99:2757-2764.
32. Collins RJ, Harmon BV, Gobe GC, et al. Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int J Radiat Biol. 1992;61:451-453.